{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:34:29Z","timestamp":1781620469271,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Foundation of Basic Research for Young Teachers of Zhengzhou University","award":["Natural Sciences. JC22862038"],"award-info":[{"award-number":["Natural Sciences. JC22862038"]}]},{"name":"the Outstanding Young Talent Cultivation Project of Henan Science and Technology Innovation Talents","award":["YXKC2022037"],"award-info":[{"award-number":["YXKC2022037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-024-04013-3","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T06:35:19Z","timestamp":1735886119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Myelitis associated with glial fibrillary acidic protein IgG: characterization and comparison with aquaporin-4 IgG and myelin oligodendrocyte glycoprotein IgG myelitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yinyin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoya","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanchang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"6","key":"4013_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/cmi.2017.142","volume":"15","author":"Y Rodriguez","year":"2018","unstructured":"Rodriguez Y, Rojas M, Pacheco Y, Acosta-Ampudia Y, Ramirez-Santana C, Monsalve DM, et al. Guillain-Barre syndrome, transverse myelitis and infectious diseases. Cell Mol Immunol. 2018;15(6):547\u201362.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"4013_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/14737175.2023.2195095","volume":"23","author":"N Tisavipat","year":"2023","unstructured":"Tisavipat N, Flanagan EP. Current perspectives on the diagnosis and management of acute transverse myelitis. Expert Rev Neurother. 2023;23(4):389\u2013411.","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"4013_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.autrev.2011.05.018","volume":"11","author":"AT Borchers","year":"2012","unstructured":"Borchers AT, Gershwin ME. Transverse myelitis. Autoimmun Rev. 2012;11(3):231\u201348.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"4013_CR4","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1212\/WNL.0000000000004796","volume":"90","author":"NL Zalewski","year":"2018","unstructured":"Zalewski NL, Flanagan EP, Keegan BM. Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses. Neurology. 2018;90(2):e96\u2013102.","journal-title":"Neurology"},{"issue":"11","key":"4013_CR5","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a Novel Meningoencephalomyelitis. JAMA Neurol. 2016;73(11):1297\u2013307.","journal-title":"JAMA Neurol"},{"issue":"3","key":"4013_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/WCO.0000000000000676","volume":"32","author":"A Kunchok","year":"2019","unstructured":"Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy. Curr Opin Neurol. 2019;32(3):452\u20138.","journal-title":"Curr Opin Neurol"},{"key":"4013_CR7","doi-asserted-by":"publisher","first-page":"1136955","DOI":"10.3389\/fimmu.2023.1136955","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xie Y, Wang Y, Liu F, Wang L, Lian Y, et al. Clinical characteristics and prognostic factors for short-term outcomes of autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective analysis of 33 patients. Front Immunol. 2023;14:1136955.","journal-title":"Front Immunol"},{"key":"4013_CR8","doi-asserted-by":"publisher","first-page":"577750","DOI":"10.1016\/j.jneuroim.2021.577750","volume":"361","author":"C Valencia-Sanchez","year":"2021","unstructured":"Valencia-Sanchez C, Flanagan EP. Uncommon inflammatory\/immune-related myelopathies. J Neuroimmunol. 2021;361:577750.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"4013_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol. 2017;81(2):298\u2013309.","journal-title":"Ann Neurol"},{"issue":"2","key":"4013_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"issue":"3","key":"4013_CR11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268\u201382.","journal-title":"Lancet Neurol"},{"key":"4013_CR12","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3389\/fimmu.2018.02802","volume":"9","author":"F Shan","year":"2018","unstructured":"Shan F, Long Y, Qiu W. Autoimmune glial fibrillary acidic protein astrocytopathy: a review of the literature. Front Immunol. 2018;9:2802.","journal-title":"Front Immunol"},{"key":"4013_CR13","doi-asserted-by":"crossref","unstructured":"Wang S, Yuan J, Liu J. Autoimmune glial fibrillary acidic protein (gfap) astrocytopa-thy accompanied with reversible Splenial Lesion Syndrome (RESLES): a Case Report and Literature Review. Brain Sci 2023;13(4).","DOI":"10.3390\/brainsci13040659"},{"key":"4013_CR14","doi-asserted-by":"crossref","unstructured":"Greco G, Masciocchi S, Diamanti L, Bini P, Vegezzi E, Marchioni E et al. Visual system involvement in glial fibrillary acidic protein astrocytopathy: two case reports and a systematic literature review. Neurol Neuroimmunol Neuroinflamm. 2023;10(5).","DOI":"10.1212\/NXI.0000000000200146"},{"issue":"12","key":"4013_CR15","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1111\/cns.14336","volume":"29","author":"XL Li","year":"2023","unstructured":"Li XL, Wang JY, Li LK, Yang CL, Zhao XL, Yang B, et al. Epstein-Barr virus: to be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy? CNS Neurosci Ther. 2023;29(12):4139\u201346.","journal-title":"CNS Neurosci Ther"},{"key":"4013_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2019.04.004","volume":"332","author":"A Kimura","year":"2019","unstructured":"Kimura A, Takekoshi A, Yoshikura N, Hayashi Y, Shimohata T. Clinical characteristics of autoimmune GFAP astrocytopathy. J Neuroimmunol. 2019;332:91\u20138.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"4013_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12883-021-02070-6","volume":"21","author":"H Di","year":"2021","unstructured":"Di H, Yin Y, Chen R, Zhang Y, Ni J, Zeng X. Uncommon manifestations of a rare disease: a case of autoimmune GFAP astrocytopathy. BMC Neurol. 2021;21(1):37.","journal-title":"BMC Neurol"},{"issue":"10","key":"4013_CR18","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1007\/s00415-023-11818-8","volume":"270","author":"Y Liang","year":"2023","unstructured":"Liang Y, Wang G, Li B, Li G, Zeng H. Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis: a retrospective study. J Neurol. 2023;270(10):4860\u20137.","journal-title":"J Neurol"},{"key":"4013_CR19","doi-asserted-by":"publisher","first-page":"578174","DOI":"10.1016\/j.jneuroim.2023.578174","volume":"382","author":"JR Zhang","year":"2023","unstructured":"Zhang JR, Zhuang S, Xu XD, Song WL, Li KR, Jiang Y, et al. Overlapping Epstein-Barr virus encephalitis and autoimmune glial fibrillary acidic protein astrocytopathy. J Neuroimmunol. 2023;382:578174.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"4013_CR20","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12192-012-0324-8","volume":"17","author":"HF Burnett","year":"2012","unstructured":"Burnett HF, Audas TE, Liang G, Lu RR. Herpes simplex virus-1 disarms the unfolded protein response in the early stages of infection. Cell Stress Chaperones. 2012;17(4):473\u201383.","journal-title":"Cell Stress Chaperones"},{"issue":"4","key":"4013_CR21","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1212\/NXI.0000000000000458","volume":"5","author":"A Salovin","year":"2018","unstructured":"Salovin A, Glanzman J, Roslin K, Armangue T, Lynch DR, Panzer JA. Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurol Neuroimmunol Neuroinflamm. 2018;5(4):e458.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"3","key":"4013_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ene.13531","volume":"25","author":"Y Long","year":"2018","unstructured":"Long Y, Liang J, Xu H, Huang Q, Yang J, Gao C, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study. Eur J Neurol. 2018;25(3):477\u201383.","journal-title":"Eur J Neurol"},{"key":"4013_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2019.05.010","volume":"98","author":"M Handoko","year":"2019","unstructured":"Handoko M, Hong W, Espineli E, Saxena K, Muscal E, Risen S. Autoimmune glial fibrillary acidic protein astrocytopathy following herpes Simplex Virus Encephalitis in a Pediatric patient. Pediatr Neurol. 2019;98:85\u20136.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"4013_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/jnnp-2018-318004","volume":"90","author":"E Sechi","year":"2019","unstructured":"Sechi E, Morris PP, McKeon A, Pittock SJ, Hinson SR, Weinshenker BG, et al. Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis. J Neurol Neurosurg Psychiatry. 2019;90(4):488\u201390.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4013_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(22)00187-9","volume":"22","author":"JL Bennett","year":"2023","unstructured":"Bennett JL, Costello F, Chen JJ, Petzold A, Biousse V, Newman NJ, et al. Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment. Lancet Neurol. 2023;22(1):89\u2013100.","journal-title":"Lancet Neurol"},{"key":"4013_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jneuroim.2018.04.016","volume":"321","author":"D Dubey","year":"2018","unstructured":"Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, et al. Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year. J Neuroimmunol. 2018;321:157\u201363.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"4013_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","volume":"89","author":"R Iorio","year":"2018","unstructured":"Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, et al. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. J Neurol Neurosurg Psychiatry. 2018;89(2):138\u201346.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"4013_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000479948","volume":"24","author":"X Yang","year":"2017","unstructured":"Yang X, Liang J, Huang Q, Xu H, Gao C, Long Y, et al. Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: Follow-Up in 7 cases. Neuroimmunomodulation. 2017;24(2):113\u20139.","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"4013_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","volume":"271","author":"T K\u00fcmpfel","year":"2024","unstructured":"K\u00fcmpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, H\u00e4u\u00dfler V, et al. Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: attack therapy and long-term management. J Neurol. 2024;271(1):141\u201376.","journal-title":"J Neurol"},{"key":"4013_CR30","doi-asserted-by":"publisher","first-page":"1266067","DOI":"10.3389\/fneur.2023.1266067","volume":"14","author":"M Sun","year":"2023","unstructured":"Sun M, Liu H, Zhu B, Liu Y, Li A, Wang L. Comparison of glial fibrillary acidic protein-immunoglobulin G-associated myelitis with myelin oligodendrocyte glycoprotein-immunoglobulin G-associated myelitis. Front Neurol. 2023;14:1266067.","journal-title":"Front Neurol"},{"issue":"3","key":"4013_CR31","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","volume":"76","author":"D Dubey","year":"2019","unstructured":"Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, et al. Clinical, radiologic, and Prognostic features of Myelitis Associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019;76(3):301\u20139.","journal-title":"JAMA Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-04013-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-04013-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-04013-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T07:09:00Z","timestamp":1735888140000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-04013-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4013"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-04013-3","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"6 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (No. 2022-KY-0053). All participants or their parents or guardians supplied informed consent for the use of their data prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}